Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, BSE has issued In-principle approval vide Ref: LOD/RIGHT/TT/FIP/920/2025-26 dated 19th September, 2025 for the proposed Right Issue; Indrayani Biotech has informed that the In-principle approval letter received from the Stock Exchange BSE is enclosed.
The above information is a part of company’s filings submitted to BSE.